GSK 208136 vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK 208136 vaccine, covering 2017-10-09 to 2017-10-09. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds [Phase 2]